The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy
Abstract Current foot-and-mouth disease (FMD) vaccines have significant limitations, including side effects due to oil emulsions at the vaccination site, a narrow spectrum of protective efficacy, and incomplete host defenses mediated by humoral immunity alone. To overcome these limitations, new FMD...
Main Authors: | Hyundong Jo, Bong Yoon Kim, So Hui Park, Hyun Mi Kim, Sung Ho Shin, Seong Yun Hwang, Su-Mi Kim, Byounghan Kim, Jong-Hyeon Park, Min Ja Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00304-9 |
Similar Items
-
Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
by: Min Ja Lee, et al.
Published: (2020-05-01) -
Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine
by: Min Ja Lee, et al.
Published: (2019-10-01) -
Analysis of Amino Acid Mutations of the Foot-and-Mouth Disease Virus Serotype O Using both Heparan Sulfate and JMJD6 Receptors
by: Gyeongmin Lee, et al.
Published: (2020-09-01) -
CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis
by: Jihye Jang, et al.
Published: (2017-09-01) -
Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs
by: Hye-Eun Jo, et al.
Published: (2019-12-01)